Objectives: We aimed to show an area-level association between the frequency of intestinal metaplasia (IM) in Helicobacter pylori-infected patients and tobacco consumption.
Introduction
S tomach cancer is one of the most frequent cancers, both in developed and developing countries, with a wide variation in incidence and mortality rates across geographical areas 1 . «Intestinal» gastric carcinomas, which are the most frequent variety and to which regional differences in the incidence of gastric cancer are attributed 2 , are preceded by atrophic gastritis, intestinal metaplasia (IM), and dysplasia. They follow a set of sequential steps 3 which is amenable to modulation by environmental and individual susceptibility factors.
Helicobacter pylori is the most important 4 risk factor for gastric cancer 5, 6 and its precursor lesions 7, 8 . Among other environmental exposures, low fruit and vegetable consumption 9 and smoking 10, 11 are established risk factors for gastric cancer. Several studies have also addressed the association between different lifestyles and the occurrence of precancerous gastric lesions, especially IM. Smoking is the most extensively studied of these lifestyle exposures and the one that most strongly increases the risk of IM and IM progression [12] [13] [14] [15] [16] [17] [18] . With respect to host genetic background, polymorphisms in genes coding for pro-inflammatory cytokines (interleukin-1B and its receptor antagonist) are responsible for increased susceptibility to the development of cancer [19] [20] [21] and precancerous lesions [22] [23] [24] .
Regional differences in the virulence of H. pylori strains 25, 26 , host genetic profile 27, 28 and response to infection 29, 30 , and exposure to environmental hazards and certain lifestyles [31] [32] [33] have all been proposed as explanations for the low incidence of gastric cancer in many countries with a high-prevalence of infection: the so-called African 34 and Asian 35 «enigmas».
Ecological 32 and individual level 36, 37 evidence supports the hypothesis of a synergistic effect between H. pylori and smoking, which suggests that the low cigarette consumption found in most African and South-Eastern Asian countries contributes to the low frequency of gastric cancer in these regions, despite the high prevalence of infection. If an area-level association between the prevalence of IM amongst the infected and smoking could also be demonstrated, this would provide further support for the hypothesis that geographical variations in the consumption of tobacco could help to explain these «enigmas».
We thereby systematically reviewed the literature to retrieve data on the prevalence of IM in different countries and performed an ecological analysis aimed at quantifying the association between the prevalence of IM in H. pylori-infected subjects and tobacco availability in each country.
Methods
Data on the prevalence of IM were obtained through a MEDLINE search using the following expression: metaplasia AND (stomach OR gastric) AND (prevalence OR incidence OR epidemiology OR epidemio* OR prev* OR incid*) NOT One reviewer (BP) screened all the references and, after reviewing the titles and abstracts and/or the full articles, excluded those that were clearly unrelated to the study subject (e.g. laboratory research, family studies) or that had an aim or sampling strategy that resulted in the oversampling of subjects presenting atrophic gastritis, IM, dysplasia, adenocarcinoma, esophageal, duodenal (e.g. trials performed on subjects with gastric precancerous lesions, studies in which the sampling strategy did not include a random or consecutive sample of subjects undergoing upper digestive endoscopy) or other non-gastric conditions (e.g. cohorts or caseseries of patients with other diseases). When more than one figure was available for a given country, preference was given to studies that analyzed more than one country (to ensure greater comparability of the methods used to assess IM), had national coverage, evaluated random samples of the general population or had the largest sample size. The previous criteria were considered in the above-mentioned order in order to select one report per country. A flow-chart of the review is presented in figure 1 .
Results from 29 countries, obtained from 22 articles, were included in the systematic review 12, . For each study, we extracted information on the country, year of publication (the dates when the studies where performed were only available for 5 studies), characteristics of the subjects evaluated, sample size, gender and age of the participants, biopsy sites, and IM prevalence in H. pylori-infected individuals, in non-infected subjects and in the sample as a whole. A summary of the characteristics of the studies included in the systematic review is presented in table 1 and data about IM prevalence is in table 2.
Estimates of tobacco availability in each country (apparent adult tobacco consumption expressed as cigarettes per adult per day) were obtained for 1990-1992 from the Tobacco and Health Report 59 , or for the nearest available year from the National Tobacco Information Online System (NATIONS) database 60 when no data were presented in the previous source (table 3) .
For the ecological analysis, we considered the prevalence of IM in antrum biopsies of H. pylori-infected subjects. When the site of the biopsy sampling was not specified, we considered prevalence figures, regardless of the location of the lesions. When data on IM prevalence were not presented separately for infected and non-infected individuals 38, 44, 46, 51 , we assumed that all the cases of IM occurred within the group of infected subjects. When H. pylori status was not analysed in the study, we considered the overall prevalence, regardless of infection status 43, 47, 58 . One country had no available data on the consumption of cigarettes in the databases searched and was therefore excluded from the ecological analysis 57 .
Pearson's correlation coefficients were computed to quantify the association between IM prevalence among the infected and tobacco availability (table 4). Data analysis was performed using STATA», version 9.2.
Results
Data on IM prevalence were obtained for 29 countries: 3 African (one from Northern and two from Western Africa), 6 American (one from North, one from Central and four from South American countries), 9 Asian (three from Eastern, 3 from Western and 3 from Southern Asia), 9 European (4 from Northern, 2 from Southern, 2 from Western, and one from Central/Eastern Europe), and 2 from Oceania (Australia and New Zealand) (table 1).
The median number of subjects evaluated in each study was 250, with sample sizes ranging from 45 to 2199. All reports included both males and females, but the number of subjects evaluated according to gender was only available for 18 countries. Among the latter, the median male/female ratio was 1.1, ranging from 0.6 to 3.2. Most studies evaluated samples with a wide agerange (from young adulthood to over 65), but 8 included participants aged below 18 (as specified by the authors or estimated assuming the minimum age as the mean minus 2 standard deviations) and 3 only enrolled participants who were over 40 years old. Twenty-five studies were carried out in a hospital setting, evaluating dyspeptic patients (table 1) .
The median number of biopsy specimens colleted was 4, ranging from 2 to 13. The data from 17 studies were based on the Sydney system, while one followed the Whitehead classification, and 11 reports did not specify the criteria used for histological assessment (table  1) . Seventeen studies provided information on antrum IM prevalence, while the other only presented data for the frequency of IM, without specifying the location of the lesions found. Seven reports did not present data for IM prevalence by H. pylori infection status (table 2) .
The median prevalence of IM among H. pylori-infected individuals was 23.6%, ranging from 3% in Argentina to 55% in New Zealand. In countries presenting a simultaneously high prevalence of infection and low gastric cancer incidence 32 , IM was also infrequent (Thailand, 6%; India, 8.2%; Nigeria, 11.1%; Gambia, 263 articles were excluded based on the abstract because they were clearly unrelated to our study or performed an oversampling presenting atrophic gastritis, intestinal metaplasia, dysplasia, adenocarcinoma, oesophageal, duodenal or other non-gastric conditions 154 articles were retrieved for further analysis 20 articles were excluded based on the full text because they performed an oversampling of subjects presenting atrophic gastritis, intestinal metaplasia, dysplasia, adenocarcinoma, oesophageal, duodenal or other non-gastric conditions 125 articles 103 articles (presenting data for countries) were excluded because when more than one figure was available for the same country we opted for studies that analyzed more than one country or with a national coverage, using random samples of the general population, with the largest sample size 22 articles were selected presenting data for 29 countries (2) Body (2) a Minimum-maximum, except when otherwise specified; b mean ± SD; c lower limit of the age range not specified. M: males; F: females. 3) . A moderately significant correlation was observed between IM prevalence in infected subjects and tobacco availability (r = 0.45; p = 0.02) ( fig. 2 ). When conducting a sensitivity analysis taking different inclusion criteria into account (table 4), the correlation coefficient point estimates were similar to those observed in the main analysis for most of the subgroups analyzed, with values ranging between 0.42 and 0.55. The only exceptions were in studies providing IM prevalence in the antrum (r = 0.33), studies providing IM prevalence in H. pylori-infected subjects (r = 0.36) and studies involving only asymptomatic subjects (r = 0.83).
Discussion
This systematic review of published data retrieved information for 29 countries from the 5 continents showing a wide variation in the prevalence of IM among H. pylori-infected subjects. We observed a moderate correlation between IM prevalence among H. pylori-infected subjects and tobacco availability.
The search strategy adopted for the systematic review included only articles published since 1996. These studies were more likely to have followed a standardized approach to the interpretation of gastric biopsies based on the updated Sydney System 61 . The criteria used to select one study per country were also defined with the aim of selecting the most reliable estimates, with the highest levels of external validity and inter-study comparability of methodologies. Preference was given to articles in which the evaluation of biopsies from patients from different countries was performed by the same authors, which helped to guarantee more homogeneous criteria in the biopsy sampling and interpretation. Studies covering asymptomatic populations within the same country tend to better reflect the prevalence of IM in the region in question and estimates obtained from larger samples are more precise.
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Corpus -1. was the main exclusion criterion) allowed an evaluation of studies based on different methodological approaches. Most of them involved dyspeptic and H. pylori-infected patients, which naturally do not reflect the prevalence of IM in the general population. Details of the latter could be obtained by evaluating samples that are not pre-selected according to gastrointestinal symptoms, but such information is only available for a small number of countries. However, our review provides important in-formation on the frequency of IM among H. pylori-infected subjects, which is not expected to differ substantially between dyspeptic and non-dyspeptic subjects, between males and females, or over time.
Even if the evaluated populations are homogeneous, the number and location of biopsy sites may contribute to variability in the prevalence of IM [62] [63] [64] . The studies included in this review showed substantial variation with respect to biopsy sites, or in their description, impairing full comparability between different countries. Here, however, we present data for each specific stomach location and most of the studies cited are based on the results of antrum biopsies. The majority of papers consulted presented information for IM at the antrum, with the greatest prevalence being observed at this location, which facilitated comparison.
Differences in the characteristics of the populations studied with regard to age could compromise comparisons between different countries. Only 3 studies 12, 40, 54 provided the information needed to obtain age-standardized IM prevalence estimates, but most of them included subjects from a wide age-range. All of the studies evaluated both males and females, but the samples do not necessarily reflect the sex ratio within the H. pylori-infected population. In addition to providing descriptive information on IM prevalence for different countries, the systematic review was also designed to provide data for an ecological analysis, and this was reflected in the characteristics of the search strategy. A more comprehensive search would probably provide information for a few more countries, but we do not believe that the conclusions of our study would be changed since we were able to include a large number of countries from five continents in our analysis.
The advantages and limitations of the ecological design are well-known 65 and certain considerations must be made with reference to the data sources and options for analysis.
The information on the frequency of IM had the previously mentioned limitations and some assumptions had to be made in order to include all of the countries in the analysis, since not all the reports presented data in the same format. Seven studies 38, 43, 44, 46, 47, 51, 58 did not provide information on the frequency of IM in H. pylori-infected subjects. They were therefore included in the ecological analysis with the assumption either that the overall prevalence of IM was the same as that among the infected (Egypt, Ireland and United Kingdom), or that all IM cases had occurred within the group of infected subjects (Gambia, Nigeria, Argentina and Iran). This seemed a reasonable and conservative option, since prevalence was underestimated in the former group (which includes 2 countries with high cigarette availability and a low or moderate IM prevalence) and overestimated in the latter (which includes three countries with a low IM prevalence and low cigarette availability). If the true figures had been used, the correlation would probably have been stronger. Furthermore, 5 of these studies were conducted in countries with a predictably high prevalence of infection, so the error in our procedure was probably low. In sensitivity analysis, the exclusion of these 7 studies reduced the variability in exposure to tobacco and also the frequency of the outcome, compromising the yield of the ecological study and resulting in a correlation coefficient of 0.36 (23% lower than that observed in the main analysis). However, we computed correlation coefficients for 11 subgroups of studies with methodological characteristics that would favour the validity of our study and obtained similar results for most of the different inclusion criteria considered. The sensitivity analysis supported the robustness of our results, when considering a small number of countries providing prevalence estimates for IM.
The availability of cigarettes derived from production, importation and exportation was used in this study to estimate tobacco use, reflecting both the prevalence and intensity of consumption. We assumed that the proportion of available cigarettes consumed, the underreporting of availability, and the use of other forms of tobacco were similar for all countries.
The tobacco estimates used related to the period 1990-1992 and assumed a lag between exposure and the onset of IM ranging from 5 to 15 years. We have, however, also included in the analysis studies published between 1996 and 2006, which probably refer to surveys performed a few years earlier. The lag time considered in our study is probably of 5 to 10 years on average. Our decision to opt for a time lag as short as 5 years, less than would normally be considered if the outcome was cancer 66 , was based on the fact that our study estimates the association between smoking and a precancerous lesion, which would be expected to appear several years before the development of gastric cancer 3 .
The prevalence of IM and cigarette consumption is strongly dependent on age and gender. An age-and sex-standardization of the prevalence of IM and cigarette consumption would have improved our analysis, but unfortunately this was not possible with the data available. It should, however, be acknowledged that we evaluated the frequency of IM among the H. pylori-infected population. This is less likely to be influenced by age than the prevalence of IM in the general population. The effect of the age and gender distributions within the samples evaluated in each study was considered in the sensitivity analysis, showing no major differences in association between IM and smoking when different inclusion criteria were considered relating to the age and gender of the participants in each survey, except in studies that evaluated more women than men.
The United Arab Emirates (UAE) were not considered in the ecological analysis because no information could be obtained for tobacco availability. However, when a value equal to their nearest neighbour (Saudi Arabia) was applied as an estimate for the UAE, the correlations between IM prevalence and smoking remained the same (r = 0.45; p = 0.01).
Our results show an area-level association between exposure to tobacco and IM prevalence in H. pylori-infected subjects, providing ecological support to the hypothesis that smoking is a risk factor for IM among the infected population. This is in agreement with the known increased risk of IM associated with tobacco consumption [14] [15] [16] and with the results of previous studies that suggest a synergistic effect between smoking and H. pylori infection for stomach cancer 32, 36 . The stronger association between smoking and IM 17,67 compared to the relatively low increase in the risk of gastric cancer among smokers 10, 68 and the low rate of progression from chronic atrophic gastritis to IM observed in Kenya 69 suggest that smoking plays a modulating role in this specific step of carcinogenesis.
It would have been interesting to have been able to account for the potential influence of genetic and other environmental factors on regional variations in the prevalence of IM among H. pylori-infected individuals. H. pylori isolates from high-risk stomach cancer populations may differ genetically from those from low-risk areas, but the presence of cagA (the only virulence marker available for a relatively large number of countries) may be of limited value in explaining these apparent «enigmas» as there is also a high prevalence of cagA + strains in countries with anticipated low frequencies of intestinal metaplasia 33, [70] [71] [72] [73] .
Our study shows that IM is relatively infrequent in H. pylori-infected subjects from African and Asian countries. They present a simultaneously high prevalence of infection and low incidence of gastric cancer (Egypt, Gambia, Nigeria, India, Iran, Saudi Arabia and Thailand), which serves to extend the concept of the African and Asian «enigmas» to precancerous lesions. Tobacco availability was positively associated with the prevalence of IM among H. pylori-infected subjects at the area-level. Although the pathogenesis of intestinal metaplasia remains unknown 1 , it is well recognized that chronic gastritis and intestinal metaplasia are precursor conditions of gastric cancer. In intestinal metaplasia, the original gastric mucosa is replaced by glandular structures bearing an intestinal phenotype. Intestinal metaplasia is one of several steps in the prolonged precancerous process of gastric cancer, mostly of the intestinal histological type. There are 2 other types of intestinal metaplasia: the complite (tpe I) and the incomplite (tpe III) type. The incomplite type is more frequently associated with dysplasia and early carcinoma and is considered a more advanced stage of the process or of higher malignant potential 2 .
Comment. Gastric intestinal metaplasia and smoking
On the other hand, there is enough evidence about the causal relationship between smoking and gastric cancer risk 3 . The study by Peleteiro and colleagues deals with a systematic review of prevalence of intestinal metaplasia among Helicobacter pylori infected individuals and the correlation with na-tional tobacco availability by means of an ecological analysis 4 .
Several case-control studies have shown the association between intestinal metaplasia and smoking. Although an ecological study is not the best appropiate epidemiological design to support the hypothesis of the role of smoking in the risk of intestinal metaplasia or in the progression from intestinal metaplasia to gastric cancer, there are no reviews published on the prevalence of intestinal metaplasia. This study provides a large, detailed, and useful information about the prevalence of intestinal metaplasia in 29 countries of five continents. Nevertheless, caution should be taken when the prevalence of intestinal metaplasia between studies and countries. The population source (clinical-or population-based), the age and the sex of participants, as well as the number of biopsies specimens, and the biopsy site, may influence the prevalence of intestinal metaplasia and therefore the comparability of results from different studies.
Information of tobacco availability in each country, expressed as the adult apparent tobacco consumption in cigarettes per day, were obtained from the Tobacco and Health Report of the WHO or from the National Tobacco Information Online System database, which provide realiable information at the population level. Despite the importance of these results, it is necessary to stress that causal relationships can be only derived from individual exposure data from studies to come.
